Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-008-0 | CAS number: 552-30-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1983-10-27 to 1983-11-22
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP proprietary study, non-standard methods
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Sub-acute inhalation toxicity study in the rat with specific investigation of respiratory sensitisation effects.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Benzene-1,2,4-tricarboxylic acid 1,2-anhydride
- EC Number:
- 209-008-0
- EC Name:
- Benzene-1,2,4-tricarboxylic acid 1,2-anhydride
- Cas Number:
- 552-30-7
- Molecular formula:
- C9H4O5
- IUPAC Name:
- 1,3-dioxo-1,3-dihydro-2-benzofuran-5-carboxylic acid
- Details on test material:
- - Name of test material (as cited in study report): Trimellitic anhydride
- Physical state: White solid in the form of flakes
- Lot/batch No.: Test Article - 128C, Identification number - 5507-133
- Storage condition of test material: Store in a tightly sealed jar in a ventilated cabinet at room temperature (approx 22°C)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The animals were male and female Sprague-Dawley rats (Charles River Breeding Laboratories, MI). The rats were approximately 7 weeks of age and weighed approximately 135 g on arrival. The rats were acclimatised for 3 weeks. After the acclimatisation period they were housed in suspended stainless steel cages. These cages were also used for the inhalation exposure. Individuals were identified by ear tags.
The animal rooms were maintained at approximately 22°C and 40% relative humidity. Fluorescent lighting was provided on a 12 hour light/dark cycle. Purina Rodent Chow 5001 and reverse osmosis purified water were provided ad libitum, except during inhalation exposure.
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Remarks on MMAD:
- MMAD / GSD: The particles were reported to be micron sized.
- Details on inhalation exposure:
- Flakes of trimellitic anhydride were ground to micron size particles in an air jet mill. The ground test article was stored in a light-tight container under nitrogen. Rats were exposed to the test substance as a particulate aerosol at one of 4 target concentrations. Controls were exposed to filtered air only.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The concentration of the test article was measured during each exposure period using HPLC and a continuous aerosol monitor (PCAM).
- Duration of treatment / exposure:
- 10 days exposure (with interim necropsies performed after 5 days)
- Frequency of treatment:
- The rats were exposed 6 hours per day, 5 days per week.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 10, 30, 100 and 300 µg/m³
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
11.1, 37.4, 100.6 and 262.3 µg/m³
Basis:
analytical conc.
- No. of animals per sex per dose:
- Five groups of rats, each consisting of 40 males and 20 females were used to assess the toxicity of trimellitic anhydride. Four of the groups were exposed to graded concentrations of the test article in air, whereas the fifth group was exposed to filtered air only and served as a control.
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- The rats were exposed 6 hours per day, 5 days per week according to the following exposure regimens (Table 1):
1) Randomly selected male rats from each group were exposed for two weeks and sacrificed;
2) A second group of male and female rats were exposed for two weeks and sacrificed
3) A third group of male and female rats were exposed for two weeks and held for 12 days without exposure. Part of this group was challenged with an additional single 6-hour exposure and sacrificed, whereas the other was sacrificed without challenge
4) A fourth group of male rats were exposed for two weeks, held 12 weeks without exposure and sacrificed - Positive control:
- A positive control was not included.
Examinations
- Observations and examinations performed and frequency:
- The rats were observed once daily for morbidity and mortality during the quarantine period. Following initiation of treatment, all rats were observed at least once daily. Rats were observed daily for adverse clinical symptoms.
Body weights were measured at study initiation, then weekly thereafter, and at study termination. After the exposure, the 12 week recovery rats were weighed biweekly. Body weights were also measured after the 18 hour fasting period, immediately prior to necropsy.
Blood samples were taken after the fasting period (prior to necropsy) for the following clinical chemistry analyses: glucose, creatinine phosphokinase, glutamic pyruvic transaminase, glutamic oxaloacetic transaminase, alkaline phosphatase, urea nitrogen, sodium, potassium, chloride, total protein and albumin. Haematology parameters determined were: total erythrocyte count, haemoglobin, haematocrit, total and differential leukocyte count. - Sacrifice and pathology:
- All rats were subject to gross necropsy followed by histopathological examination. Organ weights were recorded for the adrenals, brain, gonads, heart, kidneys, liver, lungs and spleen. The following tissues were collected and fixed in 10% neutral buffered formalin: adrenals, brain, eyes, oesophagus, femur and bone marrow, gonads, heart, duodenum, jejunum, ileum, cecum, colon, kidneys, larynx, liver, lungs, lymph nodes, nasal turbinates, pancreas, parathyroids, pituitary, prostate, seminal vesicles, salivary glands, sciatic nerve, skeletal muscle, skin, spinal cord, spleen, stomach, thymus, thyroids, tongue, trachea, urinary bladder, uterus and gross lesions. Each lung lobe was counted for red brown and total number of foci.
- Other examinations:
- Bone marrow cellularity, serum antibodies, and specialised immunopathological techniques were utilized to determine the presence of nonspecific IgG and complement (C3) in the lungs and respiratory lymph nodes.
- Statistics:
- ANOVA followed by appropriate pairwise comparisons.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- : lung
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- : lung
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- : lung
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- No deaths occurred during the study and no significant abnormal clinical chemistry or haematology changes were observed in the test article-treated groups. Absolute and relative lung weights were increased in a dose-related manner in the 10 day exposure, 12-day rested/non challenged and 12 day rested/challenged groups. Group pathological findings revealed dose-related focal areas of haemorrhage on the lungs in the 10 day exposure and 12 day rested/challenged groups. The male rats were much more severely affected than the female rats. Focal haemorrhages were not present in the 5 day exposure, 12 day rested/non challenged or 12 week rested groups. Histologic examination of the affected lungs showed that the foci observed grossly consisted of alveolar haemorrhage and cellular infiltrates. Immunoperoxidase measurements of nonspecific IgG and complement (C3) revealed that IgG and C3 were present in large amounts in affected areas of the lungs and in respiratory lymph nodes, although a relation between trimellitic anhydride (TMA) exposure concentration and IgG or C3 was not generally seen. Total serum antibodies specific against TMA were measured and the results indicated striking dose-response relationship across all time points examined. Statistical correlations among salient findings were highly significant between the number of lung foci and the lung weights and macrophage accumulation and serum antibody levels in groups receiving recent TMA exposure. The observed effects strongly suggest that TMA acts on the immune system in the classic immune complex injury syndrome. This syndrome involves the formation of an immune complex resulting from a chemical, an associated protein and antibody previously raised against the chemical. The complex activates complement which recruits and activates neutrophils. The neutrophils phagocytose the complex and in doing so produce superoxide radicals. The radicals cause lung parenchymal and capillary endothelial damage which results in local haemorrhage. TMA produced lung haemorrhage only after prior sensitization had taken place. Rapid recovery as measured by the disappearance of lung haemorrhages was observed following cessation of exposure.
IgG Quantification in Lungs and Respiratory Lymph Nodes:
10 day exposure groups:
The IgG score in alveolar macrophages was significantly increased in a dose response manner with the 10, 30, 100 and 300 µg/m3 groups relative to the controls. The IgG score in the alveolar walls and large airways was increased in the 10, 30 and 100 µg/m3 groups, but not in the 300 µg/m3 group. There were no differences in IgG levels between male and female rats at any time point examined. Complement (C3) Quantification in Lungs and Respiratory Lymph Nodes 10 day exposure groups: The quantity of C3 in alveolar macrophages was increased in a dose response manner in the 30, 100 and 300 µg/m3 groups. The C3 score in alveolar walls was increased in the 10, 30 and 100 µg/m3 groups. The C3 score in the large airways was increased in the 10 and 30 µg/m3 groups. The intensity of C3 in the focal lesions was increased in the 10 and 100 µg/m3 groups. The C3 score in the respiratory lymph nodes was increased in the 10 and 100 µg/m3 groups. There were no differences in C3 levels between male and female rats at any time point examined.
Serum Antibody Levels
1) 10 day exposure group: The mount of serum antibody was increased in a dose-response manner, and the increase was statistically significant in the 10, 30, 100 and 300 µg/m3 groups at the 1:10 dilution and the 30, 100 and 300 µg/m3 groups at the 1:50 dilution.
2) 12 day rested/nonchallenged group: The amount of serum antibody was increased in a dose-response manner, and the increase was statistically significant in the 10, 30, 100 and 300 µg/m3 groups at the 1:10 dilution and the 30, 100 and 300 µg/m3 groups at the 1:50 dilution. The antibody levels were greater in the rested/nonchallenged groups than in the 10 day exposure groups.
3) 12 week recovery group: The amount of serum antibody was increased in a dose-response manner and the increase was statistically significant in the 10, 30, 100 and 300 µg/m3 groups at the 1:10 dilution and the 30, 100 and 300 µg/m3 groups at the 1:50 dilution. Generally the antibody levels were greater in the 12 day rested/challenged groups than in the 12 day rested/nonchallenged groups, the 10 day exposure groups or the 12 week rested groups. There was no statistically significant difference between male and female serum antibody levels at any time point examined although the serum antibody levels appeared to be slightly greater in the male rats.
Effect levels
open allclose all
- Dose descriptor:
- NOAEC
- Sex:
- male/female
- Basis for effect level:
- other: Immunological effects
- Remarks on result:
- not determinable
- Remarks:
- no NOAEC identified
- Dose descriptor:
- LOAEC
- Effect level:
- 10 other: µg/m³
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Immunological effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Clear evidence of respiratory sensitisation was seen under the conditions of this study.
Applicant's summary and conclusion
- Conclusions:
- A series of adverse effects were seen during the duration of the study. The observed effects strongly suggest that trimellitic anhydride (TMA) acts on the immune system in the classic immune complex injury syndrome. TMA produced lung haemorrhage only after prior sensitization had taken place. Rapid recovery as measured by the disappearance of lung haemorrhages was observed following cessation of exposure.
It can therefore be surmised that TMA caused sensitisation due to prolonged exposure rather than an irritation. No NOAEC could be identified; the LOAEC was 10 µg/m³. - Executive summary:
Trimellitic anhydride (TMA) was administered as a particulate aerosol by inhalation at target concentrations of 10, 30, 100 and 300 µg/m³ to four groups of 40 male and 20 female Sprague-Dawley rats. A filtered air control group consisting of 40 male and 20 female rats was placed in an inhalation chamber and exposed to clean filtered air for the same duration as the test article-exposed rats. The rats were exposed 6 hours per day, 5 days per week for the following exposure regimens:
1) Randomly selected male rats from each group were exposed for two weeks and sacrificed;
2) A second group of male and female rats were exposed for two weeks and sacrificed;
3) A third group of male and female rats were exposed for two weeks and held for 12 days without exposure. Part of this group was challenged with an additional single 6-hour exposure of TMA and sacrificed, whereas the other was sacrificed without challenge;
4) A fourth group of male rats were exposed for two weeks, held 12 weeks without exposure and sacrificed.
The time weighted average concentrations for test article exposure were analytically determined to be 11.1, 37.4, 100.6 and 262.3 µg/m³ for the 10, 30, 100 and 300 µg/m³ exposure groups, respectively.
No deaths occurred during the study and no significant abnormal clinical chemistry or haematology changes were observed in the test article-treated groups. Absolute and relative lung weights were increased in a dose-related manner in the 10 day exposure, 12-day rested/non challenged and 12 day rested/challenged groups. Group pathological findings revealed dose-related focal areas of haemorrhage on the lungs in the 10 day exposure and 12 day rested/challenged groups. The male rats were much more severely affected than the female rats. Focal haemorrhages were not present in the 5 day exposure, 12 day rested/non challenged or 12 week rested groups. Histologic examination of the affected lungs showed that the foci observed grossly consisted of alveolar haemorrhage and cellular infiltrates. Immunoperoxidase measurements of nonspecific IgG and complement (C3) revealed that IgG and C3 were present in large amounts in affected areas of the lungs and in respiratory lymph nodes, although a relation between TMA exposure concentration and IgG or C3 was not generally seen. Total serum antibodies specific against TMA were measured and the results indicated striking dose-response relationship across all time points examined. Statistical correlations among salient findings were highly significant between the number of lung foci and the lung weights and macrophage accumulation and serum antibody levels in groups receiving recent TMA exposure.
The observed effects strongly suggest that TMA acts on the immune system in the classic immune complex injury syndrome. This syndrome involves the formation of an immune complex resulting from a chemical, an associated protein and antibody previously raised against the chemical. The complex activates complement which recruits and activates neutrophils. The neutrophils phagocytise the complex and in doing so produce superoxide radicals. The radicals cause lung parenchymal and capillary endothelial damage which results in local haemorrhage.
TMA produced lung haemorrhage only after prior sensitization had taken place. Rapid recovery as measured by the disappearance of lung haemorrhages was observed following cessation of exposure.
It can therefore be surmised that TMA caused sensitisation due to prolonged exposure rather than an irritation. No NOAEC could be identified in this study; the LOAEC was 10 µg/m³.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.